Status:
COMPLETED
Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Patients Hospitalized for Pre-eclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
Pre-eclampsia is a disease characterized by placental damage leading to a cascade of complications during pregnancy. It is initially manifested by high blood pressure and the presence of albumin in th...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years hospitalized for preeclampsia at the Nancy regional maternity hospital
Exclusion
- Fetal death in utero;
- Adult Person subject to a legal protection measure (guardianship, curatorship, safeguard of justice);
- Person deprived of liberty by a judicial or administrative decision;
- Person subject to psychiatric care under constraint by virtue of articles L. 3212-1 and L. 3213-1 of the Public Health Code.
Key Trial Info
Start Date :
February 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 11 2025
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT06059937
Start Date
February 26 2024
End Date
February 11 2025
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de NANCY
Vandœuvre-lès-Nancy, France, 54500